Chromatin‐modifying drugs and metabolites in cell fate control-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chromatin‐modifying drugs and metabolites in cell fate control

Published:2020-09-26 Issue:11 Volume:53 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Yao Ziyue¹²³,Chen Yu¹²³,Cao Wenhua¹²³,Shyh‐Chang Ng¹²³^ORCID

Affiliation:

1. State Key Laboratory of Stem Cell and Reproductive Biology Institute of Zoology Chinese Academy of Sciences Beijing China

2. Institute for Stem Cell and Regeneration Chinese Academy of Sciences Beijing China

3. University of Chinese Academy of Sciences Beijing China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12898

Reference169 articles.

1. Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases

2. Alzheimer’s disease, dementia, and stem cell therapy

3. Prussian blue nanocubes as a multimodal contrast agent for image-guided stem cell therapy of the spinal cord

4. Stem cell treatment for musculoskeletal disease

5. The Potential for Stem Cell Therapy in Diabetes

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetyl-CoA metabolism maintains histone acetylation for syncytialization of human placental trophoblast stem cells;Cell Stem Cell;2024-09

2. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance;Translational Oncology;2024-01

3. XAI-enabled neural network analysis of metabolite spatial distributions;Analytical and Bioanalytical Chemistry;2023-04-21

4. The dynamics of chromatin states mediated by epigenetic modifications during somatic cell reprogramming;Frontiers in Cell and Developmental Biology;2023-01-16

5. Temporal perturbation of histone deacetylase activity reveals a requirement for HDAC1–3 in mesendoderm cell differentiation;Cell Reports;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3